1. Home
  2. FNLC vs OSUR Comparison

FNLC vs OSUR Comparison

Compare FNLC & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Bancorp Inc  (ME)

FNLC

First Bancorp Inc (ME)

HOLD

Current Price

$27.68

Market Cap

288.7M

Sector

Finance

ML Signal

HOLD

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$2.51

Market Cap

177.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNLC
OSUR
Founded
1864
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.7M
177.2M
IPO Year
1999
1986

Fundamental Metrics

Financial Performance
Metric
FNLC
OSUR
Price
$27.68
$2.51
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$3.00
AVG Volume (30 Days)
17.1K
834.3K
Earning Date
01-21-2026
11-05-2025
Dividend Yield
5.32%
N/A
EPS Growth
18.07
N/A
EPS
2.81
N/A
Revenue
$88,119,000.00
$125,703,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.70
P/E Ratio
$9.90
N/A
Revenue Growth
12.70
N/A
52 Week Low
$22.11
$2.08
52 Week High
$28.71
$4.22

Technical Indicators

Market Signals
Indicator
FNLC
OSUR
Relative Strength Index (RSI) 71.52 49.89
Support Level $25.94 $2.42
Resistance Level $26.42 $2.65
Average True Range (ATR) 0.51 0.12
MACD 0.22 0.04
Stochastic Oscillator 97.19 61.64

Price Performance

Historical Comparison
FNLC
OSUR

About FNLC First Bancorp Inc (ME)

First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

Share on Social Networks: